These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6785181)

  • 21. Demonstration of arginyl-bradykinin moiety in rat HMW kininogen: direct evidence for liberation of bradykinin by rat glandular kallikreins.
    Kato H; Enjyoji K; Miyata T; Hayashi I; Oh-ishi S; Iwanaga S
    Biochem Biophys Res Commun; 1985 Feb; 127(1):289-95. PubMed ID: 3844939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in substrate and inhibitor sequence specificity of human, mouse and rat tissue kallikreins.
    Fogaça SE; Melo RL; Pimenta DC; Hosoi K; Juliano L; Juliano MA
    Biochem J; 2004 Jun; 380(Pt 3):775-81. PubMed ID: 15040788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of the segment (11-23) located in the first tandem repeat of plasma kallikrein: comparative binding studies of this and another segment (328-343) to high-molecular-mass kininogen.
    Basak A; Yuan XW; Harris R; Seidah NG; Chrétien M
    J Chromatogr; 1993 Jun; 615(2):251-64. PubMed ID: 8335703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Release of [hydroxyproline3]-kinins by tissue kallikreins of pig, rat and man.
    Maier M; Reissert G; Jerabek I; Bergmann I; Balaun E; Lottspeich F; Binder BR
    Biochem Pharmacol; 1990 Feb; 39(3):549-53. PubMed ID: 2306266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specificity of S'1 and S'2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P'1 and P'2 positions in design of inhibitors.
    Pimenta DC; Fogaça SE; Melo RL; Juliano L; Juliano MA
    Biochem J; 2003 May; 371(Pt 3):1021-5. PubMed ID: 12578561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined use of platinum(II) complexes and palladium(II) complexes for selective cleavage of peptides and proteins.
    Milović NM; Dutca LM; Kostić NM
    Inorg Chem; 2003 Jun; 42(13):4036-45. PubMed ID: 12817959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substrate specificity of cucumisin on synthetic peptides.
    Yonezawa H; Kaizuka H; Uchikoba T; Arima K; Kaneda M
    Biosci Biotechnol Biochem; 2000 Oct; 64(10):2104-8. PubMed ID: 11129582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amino acid sequence of acylphosphatase from porcine skeletal muscle.
    Mizuno Y; Yamazaki M; Takasawa T; Kizaki T; Shiokawa H
    J Biochem; 1985 Apr; 97(4):1135-42. PubMed ID: 2993259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individual reaction steps in the release of kallidin from kininogen by tissue kallikrein.
    Fiedler F; Hinz H; Lottspeich F
    Adv Exp Med Biol; 1986; 198 Pt A():283-9. PubMed ID: 3643712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study of kallikrein-like serine proteinases from rat submandibular glands.
    Bedi GS
    Prep Biochem Biotechnol; 1996 May; 26(2):85-104. PubMed ID: 8784920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monkey pepsinogens and pepsins. IV. The amino acid sequence of the activation peptide segment of Japanese monkey pepsinogen.
    Kageyama T; Takahashi K
    J Biochem; 1980 Jul; 88(1):9-16. PubMed ID: 6773933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary structure of murine major histocompatibility complex alloantigens: amino acid sequence of the amino-terminal one hundred and seventy-three residues of the H-2Kb glycoprotein.
    Uehara H; Ewenstein BM; Martinko JM; Nathenson SG; Coligan JE; Kindt TJ
    Biochemistry; 1980 Jan; 19(2):306-15. PubMed ID: 6986168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transition-metal complexes as enzyme-like reagents for protein cleavage: complex cis-[Pt(en)(H2O)2]2+ as a new methionine-specific protease.
    Milović NM; Dutca LM; Kostić NM
    Chemistry; 2003 Oct; 9(20):5097-106. PubMed ID: 14562327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substrate specificity of porcine pancreatic kallikrein.
    Fiedler F; Leysath G
    Adv Exp Med Biol; 1979; 120A():261-71. PubMed ID: 495315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of the hydrolysis of synthetic substrates by horse urinary kallikrein and trypsin.
    Sampaio MU; Galembeck F; Paiva AC; Prado ES
    Gen Pharmacol; 1976 Aug; 7(2-3):167-71. PubMed ID: 987954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tachykinins and other biologically active peptides from the skin of the Costa Rican phyllomedusid frog Agalychnis callidryas.
    Mignogna G; Severini C; Erspamer GF; Siciliano R; Kreil G; Barra D
    Peptides; 1997; 18(3):367-72. PubMed ID: 9145422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S(1)' and S(2)' subsite specificities of human plasma kallikrein and tissue kallikrein 1 for the hydrolysis of peptides derived from the bradykinin domain of human kininogen.
    Lima AR; Alves FM; Angelo PF; Andrade D; Blaber SI; Blaber M; Juliano L; Juliano MA
    Biol Chem; 2008 Dec; 389(12):1487-94. PubMed ID: 18844446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rat tissue kallikrein releases a kallidin-like peptide from rat low-molecular-weight kininogen.
    Hilgenfeldt U; Stannek C; Lukasova M; Schnölzer M; Lewicka S
    Br J Pharmacol; 2005 Dec; 146(7):958-63. PubMed ID: 16231010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiological and biochemical properties of a kallikrein-like enzyme from the venom of Vipera aspis aspis (aspic viper).
    Komori Y; Sugihara H
    Toxicon; 1988; 26(12):1193-203. PubMed ID: 3238703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation of [hydroxyproline3]Lysyl-bradykinin formed by kallikrein from human plasma protein.
    Sasaguri M; Ikeda M; Ideishi M; Arakawa K
    Adv Exp Med Biol; 1989; 247A():539-44. PubMed ID: 2603820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.